Alopecia syphilitica, from diagnosis to treatment
Proc (Bayl Univ Med Cent). 2022 Jan 26;35(2):180-183. doi: 10.1080/08998280.2021.2021761. eCollection 2022.ABSTRACTAlopecia syphilitica (AS) is an uncommon manifestation of secondary syphilis, with a prevalence that ranges from 3% to 7%. It is a nonscarring alopecia that can present in a diffuse pattern, a moth-eaten pattern, or a mixed subtype. Due to its low prevalence and similar presentation to other forms of alopecia such as alopecia areata, telogen effluvium, and tinea capitis, dermatologists must maintain a high degree of suspicion for prompt diagnosis. The diagnosis of AS is made by eliciting the patient's history,...
Source: Baylor University Medical Center Proceedings - March 9, 2022 Category: Universities & Medical Training Authors: Mojahed Mohammad K Shalabi Brooke Burgess Samiya Khan Eric Ehrsam Amor Khachemoune Source Type: research
Alopecia syphilitica, from diagnosis to treatment
Proc (Bayl Univ Med Cent). 2022 Jan 26;35(2):180-183. doi: 10.1080/08998280.2021.2021761. eCollection 2022.ABSTRACTAlopecia syphilitica (AS) is an uncommon manifestation of secondary syphilis, with a prevalence that ranges from 3% to 7%. It is a nonscarring alopecia that can present in a diffuse pattern, a moth-eaten pattern, or a mixed subtype. Due to its low prevalence and similar presentation to other forms of alopecia such as alopecia areata, telogen effluvium, and tinea capitis, dermatologists must maintain a high degree of suspicion for prompt diagnosis. The diagnosis of AS is made by eliciting the patient's history,...
Source: Baylor University Medical Center Proceedings - March 9, 2022 Category: Universities & Medical Training Authors: Mojahed Mohammad K Shalabi Brooke Burgess Samiya Khan Eric Ehrsam Amor Khachemoune Source Type: research
Alopecia syphilitica, from diagnosis to treatment
Proc (Bayl Univ Med Cent). 2022 Jan 26;35(2):180-183. doi: 10.1080/08998280.2021.2021761. eCollection 2022.ABSTRACTAlopecia syphilitica (AS) is an uncommon manifestation of secondary syphilis, with a prevalence that ranges from 3% to 7%. It is a nonscarring alopecia that can present in a diffuse pattern, a moth-eaten pattern, or a mixed subtype. Due to its low prevalence and similar presentation to other forms of alopecia such as alopecia areata, telogen effluvium, and tinea capitis, dermatologists must maintain a high degree of suspicion for prompt diagnosis. The diagnosis of AS is made by eliciting the patient's history,...
Source: Baylor University Medical Center Proceedings - March 9, 2022 Category: Universities & Medical Training Authors: Mojahed Mohammad K Shalabi Brooke Burgess Samiya Khan Eric Ehrsam Amor Khachemoune Source Type: research
Alopecia syphilitica, from diagnosis to treatment
Proc (Bayl Univ Med Cent). 2022 Jan 26;35(2):180-183. doi: 10.1080/08998280.2021.2021761. eCollection 2022.ABSTRACTAlopecia syphilitica (AS) is an uncommon manifestation of secondary syphilis, with a prevalence that ranges from 3% to 7%. It is a nonscarring alopecia that can present in a diffuse pattern, a moth-eaten pattern, or a mixed subtype. Due to its low prevalence and similar presentation to other forms of alopecia such as alopecia areata, telogen effluvium, and tinea capitis, dermatologists must maintain a high degree of suspicion for prompt diagnosis. The diagnosis of AS is made by eliciting the patient's history,...
Source: Baylor University Medical Center Proceedings - March 9, 2022 Category: Universities & Medical Training Authors: Mojahed Mohammad K Shalabi Brooke Burgess Samiya Khan Eric Ehrsam Amor Khachemoune Source Type: research
Alopecia syphilitica, from diagnosis to treatment
Proc (Bayl Univ Med Cent). 2022 Jan 26;35(2):180-183. doi: 10.1080/08998280.2021.2021761. eCollection 2022.ABSTRACTAlopecia syphilitica (AS) is an uncommon manifestation of secondary syphilis, with a prevalence that ranges from 3% to 7%. It is a nonscarring alopecia that can present in a diffuse pattern, a moth-eaten pattern, or a mixed subtype. Due to its low prevalence and similar presentation to other forms of alopecia such as alopecia areata, telogen effluvium, and tinea capitis, dermatologists must maintain a high degree of suspicion for prompt diagnosis. The diagnosis of AS is made by eliciting the patient's history,...
Source: Baylor University Medical Center Proceedings - March 9, 2022 Category: Universities & Medical Training Authors: Mojahed Mohammad K Shalabi Brooke Burgess Samiya Khan Eric Ehrsam Amor Khachemoune Source Type: research
Oral minoxidil use in androgenetic alopecia and telogen effluvium
AbstractWhile current studies have supported oral minoxidil as a novel, adjunctive therapy in non-scarring forms of alopecia, there continues to be limited data on oral minoxidil for these conditions. To assess oral minoxidil use in the treatment of androgenetic alopecia and telogen effluvium, a multi-center, retrospective analysis was conducted in 105 adult patients treated for androgenetic alopecia and/or telogen effluvium with oral minoxidil (dose range 0.625 –2.5 mg) once daily for ≥ 52 weeks, case matched by age (± 5 years) and gender with 105 controls with androgenetic alopecia and/or telogen effluvium ...
Source: Archives of Dermatological Research - March 4, 2022 Category: Dermatology Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.PMID:35130383 | DOI:10.5070/D3271055619 (Source: Dermatol Online J)
Source: Dermatol Online J - February 7, 2022 Category: Dermatology Authors: Diana Gruenstein Melissa O'Mara Samantha Hussain Pa Jacob Levitt Stacy Li Pa Jack Tom Marie Leger Source Type: research
